Home > Journals > Minerva Gastroenterologica e Dietologica > Past Issues > Articles online first > Minerva Gastroenterologica e Dietologica 2018 Apr 12

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

MINERVA GASTROENTEROLOGICA E DIETOLOGICA

A Journal on Gastroenterology, Nutrition and Dietetics


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

Minerva Gastroenterologica e Dietologica 2018 Apr 12

DOI: 10.23736/S1121-421X.18.02494-7

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Actual diagnosis of Helicobacter pylori infection

Philippe LEHOURS 1, 2

1 INSERM U1053, Université de Bordeaux, Bordeaux, France; 2 Centre National de Référence des Campylobacters et des Hélicobacters, CHU de Bordeaux, Laboratoire de Bactériologie, Bordeaux, France


PDF  


Helicobacter pylori colonizes the stomach of half of humanity. The prevalence of this infection is higher among people of low socioeconomic status and from developing countries. In the absence of effective antibiotic treatment, the infection persists decades or even lifetime. The diagnosis of H. pylori can be made by invasive methods when biopsies are obtained: culture, histological examination, polymerase chain reaction or rapid urease test. Non-invasive methods have been developed, including the urea breath test, a test of high reliability, particularly suitable for post treatment monitoring, but also the fecal antigen test, as well as the detection of antibodies in the serum. Culture is important for studying sensitivity to antibiotics, in particular clarithromycin and fluoroquinolones. The present paper presents the main diagnostic tests available today for a modern diagnosis of this bacterial infection discovered over 30 years ago.

top of page

Publication History

Article first published online: April 12, 2018
Manuscript accepted: April 4, 2018
Manuscript received: March 30, 2018

Cite this article as

Lehours P. Actual diagnosis of Helicobacter pylori infection. Minerva Gastroenterol Dietol 2018 Apr 12. DOI: 10.23736/S1121-421X.18.02494-7

Corresponding author e-mail

philippe.lehours@u-bordeaux.fr